Diana Vilar-Compte1, Adrián Camacho-Ortiz2, Samuel Ponce-de-León3. 1. Epidemiología Hospitalaria, Departamento de Infectología, Instituto Nacional de Cancerología, Av. San Fernando 22, Col. Sección XVI, 14080, Mexico City, Mexico. diana_vilar@yahoo.com.mx. 2. Departamento de Medicina Interna, Hospital Universitario José E. González, Av. Francisco I. Madero S/N, Mitras Centro, Monterrey, Nuevo León, Mexico. 3. Programa Universitario de Investigación en Salud, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Abstract
PURPOSE OF REVIEW: The purpose of this article is to review the current status of health care-related infections (HCRI) in low- and middle-income countries (LMIC). RECENT FINDINGS: HCRI in LMIC are being recognized as an important health problem globally. Despite important efforts, complex medical and non-medical problems prevail. The HCRI burden in LMIC is bigger than in developed countries, with prevalence between 5.7 and 19.1%. The impact on patients, their families, and the hospital systems is high, but has been largely underestimated. During the last 30 years, some progress has been made, with an increased awareness from the medical community and some very successful programs; however, there is a huge gap for improvement and success. In many health care facilities, there is a need of functional surveillance programs, continuous supply of antiseptics, safe water supply, personal protective equipment, essential antibiotics to treat infections, appropriate number of health care personnel trained in infection control, and appropriate health care infrastructure and political commitment.
PURPOSE OF REVIEW: The purpose of this article is to review the current status of health care-related infections (HCRI) in low- and middle-income countries (LMIC). RECENT FINDINGS: HCRI in LMIC are being recognized as an important health problem globally. Despite important efforts, complex medical and non-medical problems prevail. The HCRI burden in LMIC is bigger than in developed countries, with prevalence between 5.7 and 19.1%. The impact on patients, their families, and the hospital systems is high, but has been largely underestimated. During the last 30 years, some progress has been made, with an increased awareness from the medical community and some very successful programs; however, there is a huge gap for improvement and success. In many health care facilities, there is a need of functional surveillance programs, continuous supply of antiseptics, safe water supply, personal protective equipment, essential antibiotics to treat infections, appropriate number of health care personnel trained in infection control, and appropriate health care infrastructure and political commitment.
Authors: Miguela A Caniza; Gabriela Maron; Jonathan McCullers; Wilfrido A Clara; Rafael Cedillos; Lourdes Dueñas; Sandra Arnold; Bonnie F Williams; Elaine I Tuomanen Journal: Infect Control Hosp Epidemiol Date: 2007-10-22 Impact factor: 3.254
Authors: Bijie Hu; Lili Tao; Victor D Rosenthal; Kun Liu; Yang Yun; Yao Suo; Xiandong Gao; Ruisheng Li; Danxia Su; Hungmei Wang; Chunxia Hao; Wei Pan; Catherine L Saunders Journal: Am J Infect Control Date: 2012-10-05 Impact factor: 2.918
Authors: Victor D Rosenthal; Hu Bijie; Dennis G Maki; Yatin Mehta; Anucha Apisarnthanarak; Eduardo A Medeiros; Hakan Leblebicioglu; Dale Fisher; Carlos Álvarez-Moreno; Ilham Abu Khader; Marisela Del Rocío González Martínez; Luis E Cuellar; Josephine Anne Navoa-Ng; Rédouane Abouqal; Humberto Guanche Garcell; Zan Mitrev; María Catalina Pirez García; Asma Hamdi; Lourdes Dueñas; Elsie Cancel; Vaidotas Gurskis; Ossama Rasslan; Altaf Ahmed; Souha S Kanj; Olber Chavarría Ugalde; Trudell Mapp; Lul Raka; Cheong Yuet Meng; Le Thi Anh Thu; Sameeh Ghazal; Achilleas Gikas; Leonardo Pazmiño Narváez; Nepomuceno Mejía; Nassya Hadjieva; May Osman Gamar Elanbya; María Eugenia Guzmán Siritt; Kushlani Jayatilleke Journal: Am J Infect Control Date: 2011-09-10 Impact factor: 2.918
Authors: John S Schieffelin; Jeffrey G Shaffer; Augustine Goba; Michael Gbakie; Stephen K Gire; Andres Colubri; Rachel S G Sealfon; Lansana Kanneh; Alex Moigboi; Mambu Momoh; Mohammed Fullah; Lina M Moses; Bethany L Brown; Kristian G Andersen; Sarah Winnicki; Stephen F Schaffner; Daniel J Park; Nathan L Yozwiak; Pan-Pan Jiang; David Kargbo; Simbirie Jalloh; Mbalu Fonnie; Vandi Sinnah; Issa French; Alice Kovoma; Fatima K Kamara; Veronica Tucker; Edwin Konuwa; Josephine Sellu; Ibrahim Mustapha; Momoh Foday; Mohamed Yillah; Franklyn Kanneh; Sidiki Saffa; James L B Massally; Matt L Boisen; Luis M Branco; Mohamed A Vandi; Donald S Grant; Christian Happi; Sahr M Gevao; Thomas E Fletcher; Robert A Fowler; Daniel G Bausch; Pardis C Sabeti; S Humarr Khan; Robert F Garry Journal: N Engl J Med Date: 2014-10-29 Impact factor: 91.245
Authors: Francisco Higuera; Manuel Sigfrido Rangel-Frausto; Victor Daniel Rosenthal; Jose Martinez Soto; Jorge Castañon; Guillermo Franco; Natividad Tabal-Galan; Javier Ruiz; Pablo Duarte; Nicholas Graves Journal: Infect Control Hosp Epidemiol Date: 2007-01 Impact factor: 3.254
Authors: Margaret A Dudeck; Lindsey M Weiner; Katherine Allen-Bridson; Paul J Malpiedi; Kelly D Peterson; Daniel A Pollock; Dawn M Sievert; Jonathan R Edwards Journal: Am J Infect Control Date: 2013-12 Impact factor: 2.918
Authors: Paula Soza-Ossandón; Dácil Rivera; Kasim Allel; Gerardo González-Rocha; Mario Quezada-Aguiluz; Ivan San Martin; Patricia García; Andrea I Moreno-Switt Journal: Antibiotics (Basel) Date: 2022-05-04
Authors: Amal Alrashidi; Mohammed Jafar; Niamh Higgins; Ciara Mulligan; Carmine Varricchio; Ryan Moseley; Vildan Celiksoy; David M J Houston; Charles M Heard Journal: Biomolecules Date: 2021-12-16